Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysis.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
11 2022
Historique:
received: 01 07 2022
revised: 05 09 2022
accepted: 07 10 2022
pubmed: 29 10 2022
medline: 18 11 2022
entrez: 28 10 2022
Statut: ppublish

Résumé

Idiopathic blepharospasm is a clinically heterogeneous dystonia also characterized by non motor symptoms. We used a k-means cluster analysis to assess 188 patients with idiopathic blepharospasm in order to identify relatively homogeneous subpopulations of patients, using a set of motor and psychiatric variables to generate the cluster solution. Blepharospasm patients reached higher scores on scales assessing depressive- and anxiety-related disorders than healthy/disease controls. Cluster analysis suggested the existence of three groups of patients that differed by type of spasms, overall motor severity, and presence/severity of psychiatric problems. The greater severity of motor symptoms was observed in Group 1, the least severity in Group 3, while the severity of blepharospasm in Group 2 was between that observed in Groups 1 and 3. The three motor subtypes also differed by psychiatric features: the lowest severity of psychiatric symptoms was observed in the group with least severe motor symptoms (group 3), while the highest psychiatric severity scores were observed in group 2 that carried intermediate motor severity rather than in the group with more severe motor symptoms (group 1). The three groups did not differ by disease duration, age of onset, sex or other clinical features. The present study suggests that blepharospasm patients may be classified in different subtypes according to the type of spasms, overall motor severity and presence/severity of depressive symptoms and anxiety.

Identifiants

pubmed: 36306537
pii: S1353-8020(22)00327-3
doi: 10.1016/j.parkreldis.2022.10.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-98

Subventions

Organisme : NINDS NIH HHS
ID : U54 NS065701
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001449
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR001448
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS116025
Pays : United States
Organisme : NCATS NIH HHS
ID : U54 TR001456
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS119831
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Giovanni Defazio (G)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Angelo F Gigante (AF)

Section of Neurology, San Paolo Hospital, Bari, Italy. Electronic address: angelo.gigante@yahoo.it.

Mark Hallett (M)

Human Motor Control Section, NINDS, NIH, Bethesda, MD, USA.

Alfredo Berardelli (A)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS NEUROMED, Pozzilli, Italy.

Joel S Perlmutter (JS)

Neurology, Radiology, Neuroscience, Physical Therapy, Occupational Therapy, Washington University in St. Louis, St Louis, MO, USA.

Brian D Berman (BD)

Virginia Commonwealth University, Richmond, VA, USA.

Joseph Jankovic (J)

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.

Tobias Bäumer (T)

Institute of Systems Motor Science, University of Lübeck, Lübeck, Germany.

Cynthia Comella (C)

Rush University Medical Center, New Philadelphia, OH, USA.

Tommaso Ercoli (T)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Gina Ferrazzano (G)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Susan H Fox (SH)

Toronto Western Hospital, Krembil Brain Institute, University of Toronto, Canada.

Han-Joon Kim (HJ)

Department of Neurology and Movement Disorder Centre, Seoul National University Hospital, Seoul, South Korea.

Emile Sami Moukheiber (ES)

Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.

Sarah Pirio Richardson (SP)

Department of Neurology, University of New Mexico, Albuquerque, NM, USA.

Anne Weissbach (A)

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA; Institute of Systems Motor Science and Institute of Neurogenetics, University of Lübeck, Germany.

Hyder A Jinnah (HA)

Department of Neurology and Human Genetics, Emory University, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH